Structures by: Konovalova I. S.
Total: 42
C14H16N4O3
C14H16N4O3
RSC Advances (2012) 2, 17 6719
a=5.6370(4)Å b=10.2308(7)Å c=24.765(2)Å
α=90.00° β=90.00° γ=90.00°
C10H8N2OS
C10H8N2OS
CrystEngComm (2019)
a=7.3622(12)Å b=7.8278(13)Å c=9.5248(18)Å
α=73.758(15)° β=69.604(16)° γ=68.658(15)°
C10H8N2O2
C10H8N2O2
CrystEngComm (2019)
a=4.7260(9)Å b=14.633(3)Å c=12.5056(17)Å
α=90° β=93.970(14)° γ=90°
C10H7NO2S
C10H7NO2S
CrystEngComm (2019)
a=11.3493(10)Å b=5.6476(4)Å c=14.2419(10)Å
α=90° β=100.689(8)° γ=90°
4-nitro-o-phenylene-diamine
C6H7N3O2
CrystEngComm (2017)
a=3.6679(7)Å b=10.1769(19)Å c=17.203(3)Å
α=90° β=90° γ=90°
C2H5N5
C2H5N5
CrystEngComm (2010) 12, 3 909
a=5.3783(12)Å b=11.086(3)Å c=13.580(4)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=3.9876(5)Å b=10.6511(13)Å c=25.107(2)Å
α=90° β=90° γ=90°
Methyl 4-amino-3-phenylisothiazole-5-carboxylate
C11H10N2O2S
Acta Crystallographica Section C (2021) 77, 1
a=6.9210(9)Å b=7.2371(17)Å c=42.396(8)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=4.4041(4)Å b=27.8787(18)Å c=9.3533(8)Å
α=90° β=100.816(7)° γ=90°
3-Cyclopropyl-5-(3-methyl-[1,2,4]triazolo[4,3-<i>a</i>]pyridin-7-yl)-1,2,4-oxadiazole
C12H11N5O
Acta Crystallographica Section C (2021) 77, 1
a=12.2191(13)Å b=8.1593(9)Å c=22.788(2)Å
α=90° β=90° γ=90°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=8.4476(10)Å b=8.5662(8)Å c=8.6125(8)Å
α=110.812(9)° β=115.048(11)° γ=92.854(9)°
3-Cyclopropyl-5-(2-hydrazinylpyridin-3-yl)-1,2,4-oxadiazole
C10H11N5O
Acta Crystallographica Section C (2020) 76, 8
a=4.8240(11)Å b=8.2685(19)Å c=26.527(10)Å
α=90° β=90° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=15.611(5)Å b=3.8414(9)Å c=21.974(7)Å
α=90° β=90.74(3)° γ=90°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=3.9158(8)Å b=17.717(3)Å c=18.832(3)Å
α=90° β=94.670(16)° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=20.931(2)Å b=3.7708(5)Å c=16.0887(15)Å
α=90° β=90° γ=90°
3-[5-(Pyridin-4-yl)-1,3,4-oxadiazol-2-yl]-2<i>H</i>-chromen-2-one
C16H9N3O3
Acta Crystallographica Section C (2019) 75, 11
a=3.7788(9)Å b=9.9655(17)Å c=16.899(3)Å
α=90° β=93.466(19)° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8415(7)Å b=10.8931(12)Å c=20.163(2)Å
α=74.965(9)° β=83.815(9)° γ=72.183(10)°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=6.8355(11)Å b=19.512(3)Å c=10.881(2)Å
α=90° β=107.811(19)° γ=90°
3-(3-Phenyl-1<i>H</i>-1,2,4-triazol-5-yl)-2<i>H</i>-1-benzopyran-2-one
C17H11N3O2
Acta Crystallographica Section C (2019) 75, 6 822-832
a=13.0369(8)Å b=13.0804(7)Å c=16.2223(8)Å
α=90° β=90° γ=90°
C17H14N2O2
C17H14N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8956(7)Å b=9.6425(15)Å c=14.958(2)Å
α=103.662(13)° β=94.580(12)° γ=98.382(12)°
C16H12N2O2
C16H12N2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.8281(10)Å b=8.5805(13)Å c=15.436(2)Å
α=96.790(13)° β=95.002(15)° γ=91.404(15)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6371(13)Å b=8.957(3)Å c=15.788(6)Å
α=99.88(3)° β=96.61(3)° γ=93.21(3)°
C16H11FN2O2
C16H11FN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.6995(14)Å b=30.579(8)Å c=8.853(3)Å
α=90° β=92.70(2)° γ=90°
C16H11ClN2O2
C16H11ClN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.3746(9)Å b=30.823(5)Å c=9.855(3)Å
α=90° β=93.225(17)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=4.1661(2)Å b=31.0277(16)Å c=10.4434(6)Å
α=90° β=92.933(4)° γ=90°
C16H11BrN2O2
C16H11BrN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9397(5)Å b=10.2611(8)Å c=20.7644(12)Å
α=90° β=96.919(7)° γ=90°
C16H11IN2O2
C16H11IN2O2
Acta Crystallographica Section B (2019) 75, 5
a=6.9395(2)Å b=10.2583(4)Å c=20.7605(6)Å
α=90° β=96.931(3)° γ=90°
C17H14N2O3
C17H14N2O3
Acta Crystallographica Section B (2019) 75, 5
a=6.9921(13)Å b=10.1424(15)Å c=20.862(3)Å
α=90° β=99.570(16)° γ=90°
{μ-6,6-Dimethoxy-2,2'-[ethane-1,2-diylbis(nitrilomethanylylidene)]diphenolato}(methanol)(nitrato)nickel(II)sodium
C19H22N3NaNiO8
Acta Crystallographica Section E (2014) 70, 11 305-308
a=7.2070(10)Å b=11.0470(10)Å c=13.6190(10)Å
α=95.300(10)° β=99.810(10)° γ=99.050(10)°
N-(2-Hydroxyphenyl)-N'-phenethylsuccinamide
C18H20N2O3
Acta Crystallographica Section E (2006) 62, 12 o5475-o5476
a=19.630(4)Å b=5.1128(8)Å c=17.326(4)Å
α=90.00° β=114.17(2)° γ=90.00°
[3-Amino-5-(3,5-dimethylanilino)-4-phenylsulfonyl-2-thienyl]phenylmethanone
C25H22N2O3S2
Acta Crystallographica Section E (2007) 63, 6 o3011-o3011
a=10.497(3)Å b=11.451(3)Å c=11.863(3)Å
α=65.65(2)° β=69.654(19)° γ=70.18(2)°
Ethyl 6-ethoxy-10-(3-methoxypropyl)-9-methyl-11-thioxo-8-oxa-10,12- diazatricyclo[7.3.1.0^2,7^]trideca-2,4,6-triene-13-carboxylate
C20H28N2O5S
Acta Crystallographica Section E (2007) 63, 12 o4906-o4906
a=9.7612(16)Å b=10.3405(17)Å c=12.309(2)Å
α=107.354(13)° β=109.709(13)° γ=100.096(12)°
2-Hydroxyimino-<i>N</i>'-[1-(2-pyridyl)ethylidene]propanohydrazide
C10H12N4O2
Acta Crystallographica Section E (2009) 65, 9 o2242
a=4.4498(11)Å b=22.833(7)Å c=10.955(3)Å
α=90° β=97.47(2)° γ=90°
<i>catena</i>-Poly[calcium-bis[μ-<i>N</i>- (dimethylphosphinoyl)benzenesulfonamidato]]
C16H22CaN2O10P2S2
Acta Crystallographica Section E (2009) 65, 10 m1231
a=20.692(2)Å b=5.6750(10)Å c=22.178(3)Å
α=90.00° β=115.260(10)° γ=90.00°
<i>cis</i>-Diaquabis[dimethyl (phenylsulfonylimino)phosphonato]cobalt(II)
C16H26CoN2O12P2S2
Acta Crystallographica Section E (2011) 67, 3 m369-m370
a=9.8750(10)Å b=10.2070(10)Å c=13.345(2)Å
α=91.600(10)° β=110.590(10)° γ=92.840(10)°
<i>catena</i>-Poly[neodymium(III)-bis[μ-<i>N</i>- (dimorpholinophosphoryl)benzenesulfonamidato]-sodium(I)-bis[μ-<i>N</i>- (dimorpholinophosphoryl)benzenesulfonamidato]]
C56H84N12NdO20P4S4,Na
Acta Crystallographica Section E (2010) 66, 4 m397-m398
a=22.943(5)Å b=22.943(5)Å c=22.943(5)Å
α=90.0° β=90.0° γ=90.0°
<i>catena</i>-Poly[sodium-di-μ-aqua-sodium-bis[μ-2,2,2-trichloro-<i>N</i>- (dimorpholinophosphoryl)acetamide]]
C20H36Cl6N6Na2O10P2
Acta Crystallographica Section E (2010) 66, 4 m426-m427
a=7.522(5)Å b=10.329(4)Å c=12.451(5)Å
α=84.17(4)° β=80.89(4)° γ=70.16(5)°
Tetramethylammonium dimethyl (phenylsulfonylamido)phosphate(1-)
C4H12N,C8H11NO5PS
Acta Crystallographica Section E (2012) 68, 2 o273
a=15.2840(9)Å b=9.269(2)Å c=12.1650(11)Å
α=90.0000(10)° β=98.279(9)° γ=90.000(3)°
Tetramethyl <i>N</i>,<i>N</i>'-(2,2,3,3,4,4-hexafluoro-1,5-dioxopentane- 1,5-diyl)bis(phosphoramidate)
C9H14F6N2O8P2
Acta Crystallographica Section E (2012) 68, 4 o1127
a=19.7862(13)Å b=5.2801(4)Å c=16.9943(11)Å
α=90.00° β=100.427(6)° γ=90.00°
3-(5-Phenyl-1,3,4-oxadiazol-2-yl)-2<i>H</i>-chromen-2-one
C17H10N2O3
Acta Crystallographica Section C (2019) 75, 11
a=13.9075(11)Å b=5.1543(5)Å c=18.8010(16)Å
α=90° β=97.772(8)° γ=90°
Sodium 2-[1-methyl-5-(4-methylbenzoyl)-1<i>H</i>-pyrrol-2-yl]acetate dihydrate
2(Na),2(C15H14N1O3),4(H2O1)
Acta Crystallographica Section E (2021) 77, 2 134-137
a=8.5404(8)Å b=9.0144(9)Å c=21.6217(19)Å
α=92.922(8)° β=98.873(7)° γ=113.038(9)°